News

Cosmo Pharmaceuticals announced that clinical trial of Eleview in comparison to a standard saline solution in subjects undergoing Endoscopic Mucosal Resection (EMR) of colonic lesions…
Read More...

U.S. FDA has granted approval for MT Pharma America, Inc. RADICAVA (edaravone), as an intravenous infusion treatment for amyotrophic lateral sclerosis (ALS).  People given RADICAVA…
Read More...

Teva Pharmaceutical and Active Biotech announced that the results from the CONCERTO trial did not meet primary endpoint. The trial was based on patients with relapsing-remitting…
Read More...

BIOLASE announced that it will be initiating a search for a Chief Financial Officer as it has accepted the resignation of recent Chief Financial Officer Mark J. Nelson. Until a…
Read More...

Opsis Therapeutics announced that their executive leadership team has approved its scientific advisory board (SAB) responsible to advise on the development and advancement to the…
Read More...

Lamellar Biomedical has raised a fund of £5.75 million in a Series C equity funding round led by Invesco Asset Management Limited and supported by the Scottish Investment Bank (SIB).…
Read More...

Crown Bioscience announced collaboration with Jiangsu Qyun Bio-Pharmaceutical to develop antibody. The goal of the collaboration is to develop a less toxic CTLA-4 antibody and better…
Read More...

GenSight announced that it has appointed Mohamed Genead as Chief medical Officer, effective from May 1, 2017. He will be responsible for setting strategy for and execution of global…
Read More...

AstraZeneca announced that it entered a strategic collaboration worth $2.1 billion with Pieris Pharmaceuticals to develop novel inhaled drugs that leverage Pieris’ Anticalin platform.…
Read More...

Epizyme has earned a $10 million milestone payment from GlaxoSmithKline (GSK) to follow GSK's initiation of GLP toxicology studies for a first-in-class methyltransferase inhibitor…
Read More...

Corvus Pharmaceuticals has expanded its clinical collaboration with Genentech. Under the new agreement, CPI-444 administered in combination with atezolizumab (Tecentriq) will be…
Read More...

Provista appoints Jim Cunniff as new president and CEO who will succeed Dan Thomas. He assumed his new role with Provista on May 1, 2017. Prior to joining Provista, Cunniff was the…
Read More...

Quivive has entered into service agreements with Camargo Pharmaceutical Services. Camargo will be providing regulatory consulting and strategic development services for Quivive's…
Read More...

SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers. The study used a GMP-manufactured, non-hemagglutinating,…
Read More...

Sorrento Therapeutics  announced that Levena has completed construction and put into operation a 25,000 square foot GMP (Good Manufacturing Practice) manufacturing facility in Suzhou,…
Read More...

Alcami Corporation announced an investment of  $5 million in the expansion of its existing Charleston County operations. Alcami offers a variety of biopharmaceutical services across…
Read More...

Dragonfly Therapeutics announced that they have appointed Dr. Asya Grinberg to its senior team as Head of Biologics. Dr. Grinberg spent 12 years at Acceleron Pharma discovering…
Read More...

Vivet Therapeutics announced that it has recieved €37.5 million in a Series A financing round for advancement in developing gene therapies for treatment of rare inherited metabolic…
Read More...

BioPharmX announced that it achieved primary endpoint in its phase 2b clinical trial evaluating BPX-011. From the topline results for the study's primary endpoint, BioPharmX…
Read More...

CARsgen Therapeutics (CArsgen) announced the opening of CAR-T cell manufacturing facility in Shanghai to support CARsgen clinical programs. It is  China’s first CAR-T cell manufacturing…
Read More...